Technique | Notes | Reference |
---|---|---|
Reference methods | Â | Â |
   Hyperinsulinemic euglycemic clamp | Gold standard, highly invasive | [114] |
   Frequently sampled intravenous glucose tolerance test | Silver standard, invasive | [132] |
Oral glucose tolerance test | Â | Â |
   Insulin sensitivity glycemic index = 1 + 2/INSp × GLYp) | Most commonly used, little invasive | [133] |
   Whole body insulin sensitivity | Little invasive | [133] |
   Muscle IS = (Δglucose/Δtime)/mean plasma insulina | Little invasive | [134] |
   Hepatic IS = glucose0-30 minutes[AUC] × insulin0-30 minutes[AUC]b | Little invasive | [134] |
Fasting simple indices | Â | Â |
   Homeostasis model assessment insulin resistance (HOMA-IR) | Non-invasive | [133] |
   Newer version of the HOMA-IR (HOMA2-S) | Non-invasive | [133] |
   FGIR = fasting glucose (mg/dl)/fasting insulin (mU/l) | Non-invasive | [133] |
   Quicki = 1/(log fasting insulin (mU/l) + log fasting glucose (mg/dl)) | Non-invasive | [133] |
Biochemical markers of insulin resistance | Â | Â |
   Sex hormone binding globulin | Non-invasive | [133] |
   Insulin-like growth factor binding protein 1 | Non-invasive | [133] |
   Other markers: YKL-40, alpha-hydroxybutyrate, soluble CD36, leptin, resistin, interleukin-18, retinol binding protein-4, and chemerin | Non-invasive | [135] |